Main useUsed for selected cancers such as melanoma and lung cancer, depending on cancer type, stage or biomarkers.A brief overview of Japanese approved uses. Check the PMDA label below for product-specific conditions.
- Japan product name
- キイトルーダ点滴静注100mg
- Brand
- Keytruda
- Generic name
- Pembrolizumab
- Japanese generic name
- ペムブロリズマブ
- Chinese name
- 帕博利珠单抗
- Marketing authorization holder
- MSD株式会社
- Strengths
- 100 mg
- Dosage form
- IV infusion
- Therapeutic area
- Oncología
- Regulatory status
- Rx
- Label updated
- 2026-09-16
- TOKYO MEDI verified
- 2026-09-22
Fuente oficial
These links go directly to PMDA records for this Japanese product. Professional and patient-facing sources are separated.